Loading...
XPAR
CLARI
Market cap1.65bUSD
Jul 10, Last price  
3.97EUR
1D
-1.73%
1Q
5.87%
Jan 2017
-85.74%
IPO
-88.88%
Name

Korian SE

Chart & Performance

D1W1MN
XPAR:CLARI chart
P/E
P/S
EPS
0.00
Div Yield, %
Shrs. gr., 5y
27.44%
Rev. gr., 5y
7.08%
Revenues
5.31b
+0.54%
513,640,000607,979,000781,328,000850,584,000922,862,0001,014,806,0001,108,357,0001,356,374,0002,222,203,0002,573,304,0002,981,404,0003,130,942,0003,336,484,0003,612,502,0003,772,909,0004,137,309,0004,438,296,0004,995,583,0005,281,757,0005,310,300,000
Net income
2m
P
19,702,00023,128,00018,042,00014,985,00024,671,00021,669,00023,275,00028,576,00061,254,00058,691,000131,293,000163,324,000123,133,000114,681,00039,402,00091,115,00022,060,000-105,245,000-55,123,0001,600,000
CFO
796m
-11.51%
11,838,00048,823,00055,446,00064,861,00085,190,00098,454,000126,322,000118,559,000246,963,000244,973,000307,397,000385,179,000377,272,000765,714,000794,773,000839,965,000861,701,000652,584,000900,091,000796,460,000
Dividend
Jun 21, 20230.25 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
IPO date
Nov 23, 2006
Employees
67,000
Domiciled in
FR
Incorporated in
FR

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT